Skip to content

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By product

See full
Consumables34.4%+4.9%
Home28.5%-4.7%
Other Product Group19.2%-1.5%
Seasonal17.9%+0.6%

Other financials

Income statement

See full
Revenue$658.9M+14.2%
Gross profit$276.0M+16.4%
Operating income$69.6M+23.8%
Net income$56.4M+18.6%
EPS (diluted)$0.92+19.5%

Balance sheet

See full
Cash & equivalents$197.7M-0.7%
Total debt$710.3M+9.5%
Total equity$1.9B+9.3%
Total assets$3.0B+10.6%

Cash flow

See full
Operating cash flow$45.5M+58.5%
CapEx$25.5M-4.7%
Free cash flow$20.0M+921%

Valuation

See full
Market cap$4.32B-42.2%
Enterprise value$4.83B-39.0%
P/E17.3×-19.9×
P/S1.6×-1.6×

Profitability

See full
Gross margin40.7%+0.4pp
Operating margin11.4%+0.7pp
Net margin9.1%+0.5pp
FCF margin5.9%-1.0pp

Returns & leverage

See full
Return on equity13.8%+1.5pp
Debt / equity0.4×0.0×
Current ratio2.3×-0.5×